Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SouthernBiotech is a leading life sciences company dedicated to the development, production, and commercialization of high-quality antibodies and reagents for research and diagnostic use. Founded in 1982 by scientists from the University of Alabama at Birmingham, the company initially specialized in secondary antibodies and has since expanded to offer a vast portfolio of primary antibodies, isotype controls, and extracellular matrix proteins. Their products support a wide range of applications, including flow cytometry, ELISA, Western blotting, and immunohistochemistry. SouthernBiotech serves a global customer base across pharmaceutical, biotechnology, and academic research laboratories. The company is recognized for its expertise in antibody purification, conjugation, and custom production services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Souther.